These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 30929915)
1. Glucagon receptor antagonism increases mouse pancreatic δ-cell mass through cell proliferation and duct-derived neogenesis. Gu L; Cui X; Lang S; Wang H; Hong T; Wei R Biochem Biophys Res Commun; 2019 May; 512(4):864-870. PubMed ID: 30929915 [TBL] [Abstract][Full Text] [Related]
2. Regeneration of pancreatic non-β endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin. Zhang Y; Zhang Y; Bone RN; Cui W; Peng JB; Siegal GP; Wang H; Wu H PLoS One; 2012; 7(5):e36675. PubMed ID: 22586489 [TBL] [Abstract][Full Text] [Related]
3. Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets. Wang MY; Dean ED; Quittner-Strom E; Zhu Y; Chowdhury KH; Zhang Z; Zhao S; Li N; Ye R; Lee Y; Zhang Y; Chen S; Yu X; Leonard DC; Poffenberger G; Von Deylen A; McCorkle SK; Schlegel A; Sloop KW; Efanov AM; Gimeno RE; Scherer PE; Powers AC; Unger RH; Holland WL Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619103 [TBL] [Abstract][Full Text] [Related]
4. γ-aminobutyric acid modulates α-cell hyperplasia but not β-cell regeneration induced by glucagon receptor antagonism in type 1 diabetic mice. Gu L; Cui X; Lin X; Yang J; Wei R; Hong T; Yang K Acta Diabetol; 2023 Jan; 60(1):19-28. PubMed ID: 36129525 [TBL] [Abstract][Full Text] [Related]
6. Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets. Adriaenssens AE; Svendsen B; Lam BY; Yeo GS; Holst JJ; Reimann F; Gribble FM Diabetologia; 2016 Oct; 59(10):2156-65. PubMed ID: 27390011 [TBL] [Abstract][Full Text] [Related]
7. Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway. Wang MY; Yan H; Shi Z; Evans MR; Yu X; Lee Y; Chen S; Williams A; Philippe J; Roth MG; Unger RH Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2503-8. PubMed ID: 25675519 [TBL] [Abstract][Full Text] [Related]
8. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia. Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878 [TBL] [Abstract][Full Text] [Related]
9. Paracrine regulation of glucagon secretion: the β/α/δ model. Watts M; Ha J; Kimchi O; Sherman A Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E597-E611. PubMed ID: 26837808 [TBL] [Abstract][Full Text] [Related]
10. δ-cells and β-cells are electrically coupled and regulate α-cell activity via somatostatin. Briant LJB; Reinbothe TM; Spiliotis I; Miranda C; Rodriguez B; Rorsman P J Physiol; 2018 Jan; 596(2):197-215. PubMed ID: 28975620 [TBL] [Abstract][Full Text] [Related]
11. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia. Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577 [TBL] [Abstract][Full Text] [Related]
12. Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and Monkeys. Okamoto H; Kim J; Aglione J; Lee J; Cavino K; Na E; Rafique A; Kim JH; Harp J; Valenzuela DM; Yancopoulos GD; Murphy AJ; Gromada J Endocrinology; 2015 Aug; 156(8):2781-94. PubMed ID: 26020795 [TBL] [Abstract][Full Text] [Related]
13. The somatostatin-secreting pancreatic δ-cell in health and disease. Rorsman P; Huising MO Nat Rev Endocrinol; 2018 Jul; 14(7):404-414. PubMed ID: 29773871 [TBL] [Abstract][Full Text] [Related]
14. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes. Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124 [TBL] [Abstract][Full Text] [Related]
15. The somatostatin receptor in human pancreatic β-cells. Braun M Vitam Horm; 2014; 95():165-93. PubMed ID: 24559918 [TBL] [Abstract][Full Text] [Related]